Therefore, we report the impact of PD-L1-expressing CAFs using clinical specimens of patients with esophageal cancer and the efficacy of PD-L1 blockade for tumors with PD-L1-expressing CAFs in syngeneic murine models. This evidence concerns the gene CD274 and esophageal cancer.